Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Remitz

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Safety|May 14, 2009
Long-term safety of tacrolimus ointment in atopic dermatitisAnita Remitz, Sakari Reitamo
Expert Opinion on Pharmacotherapy|May 10, 2014
An update on current pharmacotherapy options in atopic dermatitisSakari Reitamo, Anita Remitz
Acta Dermato-Venereologica|May 13, 2025
Seasonal Variation of the Burden of Atopic Dermatitis in Finnish Primary Care: A Database Study on Effects of Weather and Air QualityEmilia Räisänen, Anita Remitz, Alexander Salava
Cutis|August 23, 2023
Economic Burden and Quality of Life of Patients With Moderate to Severe Atopic Dermatitis in a Tertiary Care Hospital in Helsinki, Finland: A Survey-Based StudyKerttu Mäkelä, Alexander Salava, Anita Remitz
The Journal of Dermatology|May 26, 2022
Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional studyAlexander Salava, Ville Salo, Anita Remitz
Acta Dermato-Venereologica|February 20, 2010
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trialJohanna Mandelin, Anita Remitz, Hannele Virtanen, et al.
Frontiers in Medicine|February 19, 2026
Topical probiotic <i>Lactobacillus lactis</i> treatment in atopic dermatitis: a placebo-controlled pilot study on tolerability and efficacyVille Salo, Anita Remitz, Antti Lauerma, et al.
American Journal of Clinical Dermatology|July 13, 2002
Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitisSakari Reitamo, Anita Remitz, Hannele Kyllönen, et al.
Acta Dermato-Venereologica|April 29, 2015
High serum total IgE predicts poor long-term outcome in atopic dermatitisVille Kiiski, Oskar Karlsson, Anita Remitz, et al.
European Journal of Dermatology : EJD|December 5, 2022
Allergic conjunctivitis: a risk factor for recurrent herpes simplex virus infections in patients with atopic dermatitisJussi Salonen, Anita Remitz, Janne Salonen, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Safety|May 14, 2009
Long-term safety of tacrolimus ointment in atopic dermatitisAnita Remitz, Sakari Reitamo
Expert Opinion on Pharmacotherapy|May 10, 2014
An update on current pharmacotherapy options in atopic dermatitisSakari Reitamo, Anita Remitz
Acta Dermato-Venereologica|May 13, 2025
Seasonal Variation of the Burden of Atopic Dermatitis in Finnish Primary Care: A Database Study on Effects of Weather and Air QualityEmilia Räisänen, Anita Remitz, Alexander Salava
Cutis|August 23, 2023
Economic Burden and Quality of Life of Patients With Moderate to Severe Atopic Dermatitis in a Tertiary Care Hospital in Helsinki, Finland: A Survey-Based StudyKerttu Mäkelä, Alexander Salava, Anita Remitz
The Journal of Dermatology|May 26, 2022
Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional studyAlexander Salava, Ville Salo, Anita Remitz
Acta Dermato-Venereologica|February 20, 2010
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trialJohanna Mandelin, Anita Remitz, Hannele Virtanen, et al.
Frontiers in Medicine|February 19, 2026
Topical probiotic <i>Lactobacillus lactis</i> treatment in atopic dermatitis: a placebo-controlled pilot study on tolerability and efficacyVille Salo, Anita Remitz, Antti Lauerma, et al.
American Journal of Clinical Dermatology|July 13, 2002
Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitisSakari Reitamo, Anita Remitz, Hannele Kyllönen, et al.
Acta Dermato-Venereologica|April 29, 2015
High serum total IgE predicts poor long-term outcome in atopic dermatitisVille Kiiski, Oskar Karlsson, Anita Remitz, et al.
European Journal of Dermatology : EJD|December 5, 2022
Allergic conjunctivitis: a risk factor for recurrent herpes simplex virus infections in patients with atopic dermatitisJussi Salonen, Anita Remitz, Janne Salonen, et al.
Pageof 3